Study: H1N1 patients in ICU respond faster with triple therapy

09/20/2013 | Medscape (free registration)

A study of 56 adults treated for severe H1N1 influenza A in an ICU at one of 25 Canadian centers found a triple dose of oseltamivir increased the speed of viral clearance, compared with standard therapy. ICU physician Anand Kumar, who presented the study at the Interscience Conference on Antimicrobial Agents and Chemotherapy, said another potential benefit to higher dosage therapy may be reducing the duration of infection control and patient isolation measures.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ